Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of LY3471851 in Participants With Eczema

ClinicalTrials.gov ID: NCT04081350

Public ClinicalTrials.gov record NCT04081350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema. The study will last up to 48 weeks and may include up to 23 visits to the study center.

Study identification

NCT ID
NCT04081350
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2019 (Actual)
Primary completion
Jun 24, 2022 (Actual)
Completion
Jun 24, 2022 (Actual)
Last update posted
Feb 20, 2024

2019 – 2022

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Arkansas Research Trials, LLC North Little Rock Arkansas 72117 —
California Dermatology & Clinical Research Institute Encinitas California 92024 —
Center For Dermatology Clinical Research, Inc. Fremont California 94538 —
Therapeutics Clinical Research San Diego California 92123 —
Clinical Science Institute Santa Monica California 90404 —
Miami Dermatology and Laser Research Miami Florida 33173 —
ForCare Clinical Research Tampa Florida 33613-1244 —
Medical Dermatology Specialists Sandy Springs Georgia 30328 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250 —
Skin Sciences Louisville Kentucky 40217 —
Derm Center Troy Michigan 48084 —
ActivMed Practices and Research Portsmouth New Hampshire 03801 —
Remington-Davis, Inc Columbus Ohio 43215 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Paddington Testing Company Inc Philadelphia Pennsylvania 19103 —
DermDox Centers for Dermatology Sugarloaf Pennsylvania 18249 —
Studies in Dermatology, LLC Cypress Texas 77433 —
Rodgers Dermatology Frisco Texas 75034 —
Progressive Clinical Research San Antonio Texas 78213 —
Complete Dermatology Sugar Land Texas 77478 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04081350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2024 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04081350 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →